Stock FRES FRESH2 GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Fresh2 Group Limited Share Price

Equities

FRES

US03635R2067

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:30:00 26/04/2024 BST 		5-day change 1st Jan Change
0.5787 USD -3.55% Intraday chart for Fresh2 Group Limited +57.13% -34.98%
04-22 Fresh2 Group Receives Nasdaq Notice of Non-Compliance MT
03-21 ADRs Edge Higher; Lufax Climbs Almost 46% DJ

Financials

Sales 2021 17.99M 2.48M 199M Sales 2022 12.04M 1.66M 133M Capitalization 65.83M 9.08M 728M
Net income 2021 -119M -16.42M -1.32B Net income 2022 -102M -14.08M -1.13B EV / Sales 2021 8.1 x
Net Debt 2021 22.46M 3.1M 248M Net Debt 2022 8.8M 1.21M 97.22M EV / Sales 2022 6.2 x
P/E ratio 2021
-0.89 x
P/E ratio 2022
-0.61 x
Employees 75
Yield 2021 *
-
Yield 2022
-
Free-Float 68.46%
More Fundamentals * Assessed data

Chart Fresh2 Group Limited

Dynamic Chart

Latest news about Fresh2 Group Limited

Fresh2 Group Receives Nasdaq Notice of Non-Compliance MT
ADRs Edge Higher; Lufax Climbs Almost 46% DJ
ADRs End Flat, Ehang Holdings Ltd. Climbs 15.6% DJ
Fresh2 Group Limited announced that it has received $13.512496 million in funding CI
ADRs End Flat, Fresh2 Group Ltd. Climbs 47.7% DJ
Fresh2 Group Ltd Launches TikTok Video E-commerce Venture, Bridging the Gap Between Food Sources and Consumers CI
ADRs Close Higher; Airnet Technology Climbs 54% DJ
Dollar slides versus yen as Japan warns against rapid fall RE
JGB yields track US peers up as investors weigh weak yen's impact on BOJ path RE
Dollar reigns as hot inflation cools Fed cut bets RE
Dollar reigns supreme as hot CPI cools bets for Fed cuts RE
ADRs Close Lower, Polestar Automotive Holding UK PLC Wt Declines 35.3% DJ
ADRs End Higher; Morphosys Climbs 56% DJ
Stocks strong, yields dip, this week's excitement still to come RE
ADRs End Lower; Evaxion Biotech A/S Drops 45% DJ
More news

Analyst Recommendations on Fresh2 Group Limited

Euro zone bonds hold steady as ECB officials push back on early rate cut bets RE
Euro zone bond investors on hold after ECB officials push back against rate cut bets RE
Euro area yields hit 2-1/2-month low, markets price in 100 bps of rate cuts RE
Euro zone yields rise after data, markets raise bets on September ECB rate hike RE
More recommendations

Press releases Fresh2 Group Limited

Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq GL
Fresh2 Launches TikTok Video E-commerce Venture, Bridging the Gap Between Food Sources and Consumers GL
Fresh2 Group Ltd. Announces Receipt of a Bid Deficiency Notice from Nasdaq GL
Appointment of New Independent Director PR
Fresh2 Group Launches Roxe Restaurant Robots, Spearheading Smart Automation in Culinary Services PR
More press releases

Quotes and Performance

1 day-3.55%
1 week+57.13%
Current month+5.22%
1 month-9.58%
3 months+37.79%
6 months-45.41%
Current year-34.98%
More quotes

Highs and lows

1 week
0.38
Extreme 0.3774
0.66
1 month
0.32
Extreme 0.32
0.66
Current year
0.30
Extreme 0.2999
0.90
1 year
0.30
Extreme 0.2999
9.17
3 years
0.30
Extreme 0.2999
121.53
5 years
0.30
Extreme 0.2999
243.60
10 years
0.30
Extreme 0.2999
243.60
More quotes

Managers and Directors - Fresh2 Group Limited

Managers TitleAgeSince
Hao Han Xu CEO
 Chief Executive Officer 29 02/10/22
He Yu FOU
 Founder 67 31/12/09
Chang Yu CEO
 Chief Executive Officer 66 31/12/09
Members of the board TitleAgeSince
Zhi Gang Zhao BRD
 Director/Board Member 64 02/10/22
Tian Ruo Pu BRD
 Director/Board Member 55 02/10/22
Chang Yu CEO
 Chief Executive Officer 66 31/12/09
More insiders

Quotes

Date Price Change Volume
26/04/24 0.5787 -3.55% 135,472
25/04/24 0.6 +33.63% 93,460
24/04/24 0.449 -4.47% 68,902
23/04/24 0.47 +20.82% 270,428
22/04/24 0.389 +5.62% 76,813

Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm

More quotes

Company Profile

AnPac Bio-Medical Science Co Ltd is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States. The Company is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.
Sector
Biotechnology & Medical Research
Calendar
13/05/2024 - Q4 2023 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

1st Jan change Capi.
FRESH2 GROUP LIMITED Stock Fresh2 Group Limited
-34.98% 12.86M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.45% 10.82B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+43.17% 3.25B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-35.86% 2.11B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-17.21% 2.08B
VERACYTE, INC. Stock Veracyte, Inc.
-29.81% 1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.56% 1.02B
SEEGENE, INC. Stock Seegene, Inc.
-4.37% 733M
CAREDX, INC Stock CareDx, Inc
-37.00% 391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 377M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. FRES Stock